RZN Nutraceuticals, Inc. Report issue

For profit Phase 2
Founded: Miami FL United States (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2011
NCT01135784
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (5)

dandelion (1 trial)

goldenrod (1 trial)

juniper (1 trial)

meadowsweet (1 trial)

willow bark (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Headache (Phase 2)

Migraine Disorders (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 5